Multibagger Debut! Medicamen Organics stock debuts with 305% premium on NSE SME platform

Medicamen Organics, a pharmaceutical company, saw a successful listing on the NSE SME platform with a substantial premium. The company focuses on international markets, diverse pharmaceutical dosage forms, and global expansion strategies, reflecting its growth potential and market adaptability.